Is long-term prognosis related to mid-term changes of glucometabolic status in patients with acute myocardial infarction treated invasively?
Prognosis for patients with confirmed abnormal glucose tolerance was unfavorable, however patients with abnormal glucose tolerance at discharge in whom glucometabolic status improved had similar mortality to subjects with persistent normal glucose tolerance. The major clinical implication from this study is finding that reassessment of glucometabolic status by repeated oral glucose tolerance test has significant prognostic value and makes initial risk stratification performed at discharge more reliable.
According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.